1.CMV colitis in a diabetic patient without administration of immunosuppressive agents.
Pil Soo SUNG ; Jin Sun JANG ; Bong Yun CHA
Korean Journal of Medicine 2010;79(5):504-505
No abstract available.
Colitis
;
Humans
;
Immunosuppressive Agents
2.Three Cases of Herpes Zoster Infections in immunosuppressants Patients.
Young Hoon SONG ; Bok Hee OH ; Woo Gill LEE
Journal of the Korean Pediatric Society 1982;25(11):1155-1158
No abstract available.
Herpes Zoster*
;
Humans
;
Immunosuppressive Agents*
3.Immunosuppressed model for experimental mice by cyclophosphamid
Journal of Vietnamese Medicine 2004;296(3):57-60
Study on white mices with age of 6-8 weeks, 18-20g body weight. They were divided into 3 groups: group 1 (control group): 30 mices; group 2: mices were immunesuppressed by 200mg cyclophosphamid per one kilogram of body weight, being checked after 5 days of injection; and 300mg cyclophosphamid per one kilogram (200mg on the first day and 100mg on the fifth day) and it was checked after 10 days of injection (group 3). The results: immunesuppressed model implemented by intraperitonial injection of 200mg per one kilogram of body weight checked after 5 days of injeciton. These parameters were used to assign the immune function
Immunosuppressive Agents
;
Mice
;
Animal Experimentation
;
Cyclophosphamide
4.A Case of Iatrogenic Kaposi's Sarcoma Developed in a Psoriasis Patient after a Long-term Use of Immunosuppressive Agents.
Jun Yeong PARK ; Ji Yun JUNG ; Bok Won PARK ; Eun Byul CHO ; Eun Joo PARK ; Kwang Ho KIM ; Kwang Joong KIM
Korean Journal of Dermatology 2017;55(6):372-374
No abstract available.
Cyclosporine
;
Humans
;
Immunosuppressive Agents*
;
Psoriasis*
;
Sarcoma, Kaposi*
5.A Case of Iatrogenic Kaposi's Sarcoma Developed in a Psoriasis Patient after a Long-term Use of Immunosuppressive Agents.
Jun Yeong PARK ; Ji Yun JUNG ; Bok Won PARK ; Eun Byul CHO ; Eun Joo PARK ; Kwang Ho KIM ; Kwang Joong KIM
Korean Journal of Dermatology 2017;55(6):372-374
No abstract available.
Cyclosporine
;
Humans
;
Immunosuppressive Agents*
;
Psoriasis*
;
Sarcoma, Kaposi*
6.The response to immunosuppressive agents in the adult patients with idiopathic nephrotic syndrome.
Seong Ho KIM ; Jae Hyung AHN ; Won Do PARK ; Tae Won LEE ; Chun Gyoo IHM ; Myung Jae KIM
Korean Journal of Nephrology 1992;11(4):377-385
No abstract available.
Adult*
;
Humans
;
Immunosuppressive Agents*
;
Nephrotic Syndrome*
7.Biosynthesis of immunosuppressant tacrolimus: a review.
Liqun JIN ; Di LU ; Minglin XING ; Xianwen WANG ; Zhiqiang LIU ; Yuguo ZHENG
Chinese Journal of Biotechnology 2023;39(8):3095-3110
Tacrolimus (FK506) is a 23-membered macrolide with immunosuppressant activity that is widely used clinically for treating the rejection after organ transplantation. The research on tacrolimus production was mainly focused on biosynthesis methods, within which there are still some bottlenecks. This review summarizes the progress made in tacrolimus biosynthesis via modification of metabolic pathways and control of fermentation process, with the hope to address the technical bottlenecks for tacrolimus biosynthesis and improve tacrolimus production by fermentation engineering and metabolic engineering.
Tacrolimus
;
Immunosuppressive Agents
;
Fermentation
;
Macrolides
;
Anti-Bacterial Agents
8.A Case of Multiple Dermatofibromas in a Healthy Adult.
Ki Sung KIM ; Joo Won KIM ; Hyun Chul CHOI ; Il Hwan KIM ; Hae Jun SONG ; Chil Hwan OH
Annals of Dermatology 2000;12(3):199-201
Multiple dermatofibromas are rare and some case reports show this disease has been related to generalized defective immune function: autoimmune disease and altered immunity, such as AIDS and systemic lupus erythematosus(SLE), can be treated with immunosuppressive agents. But there are no specific reports of this disease developing in healthy people. We describe a case of multiple dermatofibromas in a 38-year-old healthy man who showed no abnormality of the immune function.
Adult*
;
Autoimmune Diseases
;
Histiocytoma, Benign Fibrous*
;
Humans
;
Immunosuppressive Agents
Result Analysis
Print
Save
E-mail